Joseph Zakrzewski
Founder at AN2 THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Thero | M | 63 | 15 years | |
| David Ricks | M | 56 | 28 years | |
| Shacey Petrovic | F | 50 | 9 years | |
| Karen Smith | M | 56 | 7 years | |
| Eric Easom | M | 56 | 7 years | |
| Aaron Berg | M | 61 | 12 years | |
| Jean George | F | 66 | 19 years | |
| Stanley Abel | M | - |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | 10 years |
| Deborah Gordon | F | 54 | 10 years | |
| Prathyusha Durabaibu | F | 46 | 5 years | |
| Patricia Martin | F | 63 | 30 years | |
| Charles E. Stacey | M | - |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | 9 years |
| Aaron Rosenberg | M | - | 3 years | |
| Markus Renschler | M | 63 | 8 years | |
| Claude H. Nash | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Timothy Scannell | M | 59 | 10 years | |
| Kabeer Aziz | M | 34 | 5 years | |
| Stephanie Wong | F | 50 | 3 years | |
| Jessica Hopfield | M | 59 | 9 years | |
| Rita Karachun | F | 63 | 3 years | |
| Jerris Knaisch | F | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Valérie Leroy | F | - | 8 years | |
| Michael Minogue | M | 57 | 7 years | |
| Michael R. K. Alley | M | - | 7 years | |
| Stephen Sands | M | 67 | 2 years | |
| Anat Ashkenazi | F | 51 | 23 years | |
| Travis Coy | M | 43 | 21 years | |
| David Gaiero | M | 45 | 4 years | |
| John Markels | M | 58 | 4 years | |
| Alonzo Weems | M | - | 27 years | |
| Gilbert Marks | M | 66 | 4 years | |
| Louise Wilkie | F | - | 4 years | |
| Robin Readnour | M | 59 | 5 years | |
| Gregory Davis | M | - | 4 years | |
| Melvin Spigelman | M | 75 | 2 years | |
| Kenneth Hillan | M | 63 | 4 years | |
| James E. Malackowski | M | 60 |
Licensing Executives Society
| - |
| Jon Filderman | M | - | 3 years | |
| François Painchaud | M | 60 |
Licensing Executives Society
| - |
| Martin H. Singer | M | 72 |
Licensing Executives Society
| - |
| James Meyers | M | 59 | 5 years | |
| John C. Paul | M | - |
Licensing Executives Society
| - |
| Paul A. Roberts | M | - |
Licensing Executives Society
| - |
| Phillip W. Barnett | M | - |
Licensing Executives Society
| - |
| Pamela R. Demain | F | - |
Licensing Executives Society
| - |
| Caroline Rockafellow | F | - |
Licensing Executives Society
| - |
| Michael Q. Lee | M | - |
Licensing Executives Society
| - |
| Lucy Day | F | 65 | 5 years | |
| Steven Ketchum | M | 59 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | 16 years |
| Vicki L. Morgan | F | - |
Licensing Executives Society
| - |
| Hans-Jurgen Woerle | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Rimma Driscoll | F | - |
Licensing Executives Society
| - |
| KiKab Kim | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Thomas Reilly | M | 52 | 2 years | |
| Josh Eizen | M | - | - | |
| Jong Rho | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Richard Purcell | M | 63 |
Licensing Executives Society
| - |
| Timothy P. Maloney | M | - |
Licensing Executives Society
| - |
| Samuel Henderson | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| David Keenan | M | - | 2 years | |
| Gurpreet Singh Vohra | M | 50 |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| David Foord | M | - |
Licensing Executives Society
| - |
| Tanya Moore | F | - |
Licensing Executives Society
| - |
| Butch L. Mercer | M | - |
Licensing Executives Society
| - |
| Robert Goldman | M | - |
Licensing Executives Society
| - |
| Alison Aubry Richards | F | - |
Licensing Executives Society
| - |
| Don Drinkwater | M | - |
Licensing Executives Society
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam Veness | M | 38 | 9 years | |
| Karim Mikhail | M | 53 | 3 years | |
| Patrick Sullivan | M | 72 | 5 years | |
| Timothy Romberger | M | 52 | 11 years | |
| Michael J. Farrell | M | 45 | 3 years | |
| John L. Knopf | M | 71 | 13 years | |
| Patrick J. Langlois | M | 78 | 5 years | |
| William Ringo | M | 78 | 37 years | |
| Michael Levitz | M | 50 | 4 years | |
| Duane DeSisto | M | 69 | 13 years | |
| Jason Marks | M | 48 | 1 years | |
| Kathy Yi | F | 52 | 2 years | |
| Habib Dable | M | 54 | 5 years | |
| Derica Rice | M | 59 |
Indiana University
| 17 years |
| Gary Loeb | M | 54 | 2 years | |
| John Quisel | M | 53 | 14 years | |
| Joan Lau | M | 53 |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | - |
| Francois Nader | M | 67 | 7 years | |
| Carl Gordon | M | 59 | 7 years | |
| Joseph T. Kennedy | M | 56 | 10 years | |
| Ellen Marram | F | 77 | 17 years | |
| Daniel Levangie | M | 73 | 6 years | |
| Susan Mahony | M | 59 | 18 years | |
| Richard Pops | M | 62 |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | 15 years |
| Randall L. Tobias | M | - | 12 years | |
| Val de Vassal | M | - |
Drexel University
| 10 years |
| Win Bischoff | M | 81 | 14 years | |
| Kristine Peterson | F | 64 | 13 years | |
| Webster Dunbar | M | 62 | 5 years | |
| Lisa M. DeFrancesco | F | 45 | - | |
| Erin Enright | F | 63 | 1 years | |
| Jeffrey Henderson | M | 59 | 7 years | |
| Robert A. Armitage | M | 75 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 79 | 79.00% |
| Ireland | 13 | 13.00% |
| France | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Joseph Zakrzewski
- Personal Network